Orbus Pharma Inc., (TSX:ORB) (“Orbus”) today announced favorable results in its drug development of a once per day formulation for Fluvastatin, a cholesterol reducing drug.
Orbus Pharma Inc., (TSX:ORB) (“Orbus”) today announced favorable results in its drug development of a once per day formulation for Fluvastatin, a cholesterol reducing drug.